Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells

Por Chellaiah Meenakshi A, Rogers Michael J, Desai Bhavik
Publicado em 2007-03-01

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells

Por Desai, Bhavik, Rogers, Michael J, Chellaiah, Meenakshi A
Publicado em 2007

The regulation of osteoclast function and bone resorption by small GTPases

Por Itzstein, Cecile, Coxon, Fraser P, Rogers, Michael J
Publicado em 2011

RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro

Por Sutherland, Karen A, Rogers, Helena L, Tosh, Denise, Rogers, Michael J
Publicado em 2009

Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP

Por Roelofs, Anke J, Jauhiainen, Marjo, Mönkkönen, Hannu, Rogers, Michael J, Mönkkönen, Jukka, Thompson, Keith
Publicado em 2009

Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro

Por Räikkönen, Johanna, Crockett, Julie C, Rogers, Michael J, Mönkkönen, Hannu, Auriola, Seppo, Mönkkönen, Jukka
Publicado em 2009

A Class III Semaphorin (Sema3e) Inhibits Mouse Osteoblast Migration and Decreases Osteoclast Formation In Vitro

Por Hughes, Alun, Kleine-Albers, Jennifer, Helfrich, Miep H., Ralston, Stuart H., Rogers, Michael J.
Publicado em 2012

Impaired prenylation of Rab GTPases in the gunmetal mouse causes defects in bone cell function

Por Taylor, Adam, Mules, Emilie H, Seabra, Miguel C, Helfrich, Miep H, Rogers, Michael J, Coxon, Fraser P
Publicado em 2011

Apomine Enhances the Antitumor Effects of Lovastatin on Myeloma Cells by Down-Regulating 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase

Por Roelofs, Anke J., Edwards, Claire M., Russell, R. Graham G., Ebetino, F. Hal, Rogers, Michael J., Hulley, Philippa A.
Publicado em 2007

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

Por Whyte, Lauren S., Ryberg, Erik, Sims, Natalie A., Ridge, Susan A., Mackie, Ken, Greasley, Peter J., Ross, Ruth A., Rogers, Michael J.
Publicado em 2009

Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia

Por Ebrahim, Seham, Ingham, Neil J., Lewis, Morag A., Rogers, Michael J.C., Cui, Runjia, Kachar, Bechara, Pass, Johanna C., Steel, Karen P.
Publicado no Cell Rep (2016)

A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton

Por Ali, Naveid, Jurczyluk, Julie, Shay, Gemma, Tnimov, Zakir, Alexandrov, Kirill, Munoz, Marcia A, Skinner, Oliver P, Pavlos, Nathan J, Rogers, Michael J
Publicado no Small GTPases (2015)

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs

Por Kavanagh, Kathryn L., Guo, Kunde, Dunford, James E., Wu, Xiaoqiu, Knapp, Stefan, Ebetino, Frank H., Rogers, Michael J., Russell, R. Graham G., Oppermann, Udo
Publicado em 2006

Signal peptide mutations in RANK prevent downstream activation of NF-κB

Por Crockett, Julie C, Mellis, David J, Shennan, Kathleen IJ, Duthie, Angela, Greenhorn, John, Wilkinson, Debbie I, Ralston, Stuart H, Helfrich, Miep H, Rogers, Michael J
Publicado em 2011

A role for L-α-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells

Por Ford, Lesley A, Roelofs, Anke J, Anavi-Goffer, Sharon, Mowat, Luisa, Simpson, Daniel G, Irving, Andrew J, Rogers, Michael J, Rajnicek, Ann M, Ross, Ruth A
Publicado em 2010

Synthesis and characterization of novel fluorescent nitrogen-containing bisphosphonate imaging probes for bone active drugs

Por Sun, Shuting, Błażewska, Katarzyna M., Kashemirov, Boris A., Roelofs, Anke J., Coxon, Fraser P., Rogers, Michael J., Ebetino, Frank H., McKenna, Michael J., McKenna, Charles E.
Publicado em 2011

Phosphonocarboxylates Inhibit the Second Geranylgeranyl Addition by Rab Geranylgeranyl Transferase

Por Baron, Rudi A., Tavaré, Richard, Figueiredo, Ana C., Błażewska, Katarzyna M., Kashemirov, Boris A., McKenna, Charles E., Ebetino, Frank H., Taylor, Adam, Rogers, Michael J., Coxon, Fraser P., Seabra, Miguel C.
Publicado em 2009

The Mesenchymal Stem Cell Marker CD248 (Endosialin) Is a Negative Regulator of Bone Formation in Mice

Por Naylor, Amy J., Azzam, Eman, Smith, Stuart, Croft, Adam, Poyser, Callum, Duffield, Jeremy S., Huso, David L., Gay, Steffen, Ospelt, Caroline, Cooper, Mark S., Isacke, Clare, Goodyear, Simon R., Rogers, Michael J., Buckley, Christopher D.
Publicado em 2012

THE BISPHOSPHONATE ZOLEDRONIC ACID DECREASES TUMOR GROWTH IN BONE IN MICE WITH DEFECTIVE OSTEOCLASTS

Por Hirbe, Angela C., Roelofs, Anke J., Floyd, Desiree H., Deng, Hongju, Becker, Stephanie N., Lanigan, Lisa G., Apicelli, Anthony J., Xu, Zhiqiang, Prior, Julie L., Eagleton, Mark C., Piwnica-Worms, David, Rogers, Michael J., Weilbaecher, Katherine
Publicado em 2009

Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases

Por Jurczyluk, Julie, Munoz, Marcia A, Skinner, Oliver P, Chai, Ryan C, Ali, Naveid, Palendira, Umaimainthan, Quinn, Julian MW, Preston, Alexandra, Tangye, Stuart G, Brown, Andrew J, Argent, Elizabeth, Ziegler, John B, Mehr, Sam, Rogers, Michael J
Publicado no Immunol Cell Biol (2016)